Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Location: United States, Texas, Austin
Total raised: $8.5M
Investors 8
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.10.2013 | Series C | $8.5M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 18.02.2021 | Molecular Templates, Inc. Announces Pricing of $75.9 Million... | AUSTIN, Texas, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Comp... | globenewsw... |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of its... | hitconsult... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
| 21.07.2020 | MOLECULAR TEMPLATES, INC. Molecular Templates, Inc. Raises ... | AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular... | marketscre... |
| 21.07.2020 | Molecular Templates Raises $43 Million | AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinica... | citybizlis... |
| 08.10.2013 | Molecular Templates Raises $8.5M Series C Financing | Molecular Templates, Inc., a Georgetown, TX-based biopharmaceutical company focused on the discovery... | finsmes.co... |